Type 2 innate lymphocytes in allergic airway inflammation

Current Allergy and Asthma Reports

Volumn 13, Issue 3, 2013, Pages 271-280

  Klein Wolterink, Roel G J ^a,b,c,d   Hendriks, Rudi W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUT PASTEUR   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Allergic airway inflammation; Cytokines; Gata3; HDM; House dust mite; IL 13; IL 25; IL 33; IL 5; Influenza; Innate lymphoid cells (ILC); Mouse models; TSLP; Type 2 innate lymphocytes

Indexed keywords

ALLERGEN; GLYCOLIPID; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PAPAIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA 3;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHILIA; GENE DELETION; GENETIC ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPOIESIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TRANSCRIPTION REGULATION; TYPE 2 INNATE LYMPHOCYTE;

ALLERGENS; ANIMALS; ASTHMA; CYTOKINES; HUMANS; HYPERSENSITIVITY; LYMPHOCYTES; RESPIRATORY MUCOSA;

EID: 84877923896     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0346-z     Document Type: Review

References (97)

1. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev. 2011;242:31-50.
2. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716-25.
3. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242:10-30.
4. Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet. 2011;43:887-92.
5. Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet. 2011;43:893-6.
6. Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10:838-48.
7. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008;8:218-30.
8. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells - how did we miss them? Nat Rev Immunol. 2013;13:75-87. Excellent review on development and function of ILC subsets.
9. Kelly KA, Scollay R. Seeding of neonatal lymph nodes by T cells and identification of a novel population of CD3-CD4+ cells. Eur J Immunol. 1992;22:329-34.
10. Mebius RE, Rennert P, Weissman IL. Developing lymph nodes collect CD4+CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity. 1997;7:493-504.
11. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145-9.
12. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, et al. A thymic stromal cell line supports in vitro development of surface IgM + B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321-8.
13. Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc Natl Acad Sci U S A. 2007;104:914-9.
14. Zhang Y, Zhou B. Functions of thymic stromal lymphopoietin in immunity and disease. Immunol Res. 2012;52:211-23.
15. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med. 2003;197:1059-63.
16. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med. 2005;202:829-39.
17. Shi L, Leu SW, Xu F, Zhou X, Yin H, et al. Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells. Clin Immunol. 2008;129:202-10.
18. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15:985-95.
19. Angkasekwinai P, Park H, Wang YH, Chang SH, Corry DB, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007;204:1509-17.
20. Zhao A, Urban Jr JF, Sun R, Stiltz J, Morimoto M, et al. Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J Immunol. 2010;185:6921-9.
21. Terrier B, Bieche I, Maisonobe T, Laurendeau I, Rosenzwajg M, et al. Interleukin-25: A cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood. 2010;116:4523-31.
22. Dolgachev V, Petersen BC, Budelsky AL, Berlin AA, Lukacs NW. Pulmonary IL-17E (IL-25) production and IL-17RB + myeloid cell-derived Th2 cytokine production are dependent upon stem cell factor-induced responses during chronic allergic pulmonary disease. J Immunol. 2009;183:5705-15.
23. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34:149-62.
24. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol. 2008;181:4299-310.
25. Ballantyne SJ, Barlow JL, Jolin HE, Nath P, Williams AS, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol. 2007;120:1324-31.
26. Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol. 2010;11:250-6.
27. Jung JS, Park BL, Cheong HS, Bae JS, Kim JH, et al. Association of IL-17RB gene polymorphism with asthma. Chest. 2009;135:1173-80.
28. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 1998;187:787-94.
29. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-90.
30. Palmer G, Lipsky BP, Smithgall MD, Meininger D, Siu S, et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine. 2008;42:358-64.
31. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A. 2007;104:18660-5.
32. Schneider E, Petit-Bertron AF, Bricard R, Levasseur M, Ramadan A, et al. IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol. 2009;183:3591-7.
33. Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine. 2007;40:216-25.
34. Chow JY, Wong CK, Cheung PF, Lam CW. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cell Mol Immunol. 2010;7:26-34.
35. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol. 2008;181:4780-90.
36. Xu D, Jiang HR, Kewin P, Li Y, Mu R, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A. 2008;105:10913-8.
37. Guo L, Wei G, Zhu J, Liao W, Leonard WJ, et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A. 2009;106:13463-8.
38. Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol. 2012;33:389-96.
39. Talabot-Ayer D, Calo N, Vigne S, Lamacchia C, Gabay C, et al. The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J Leukoc Biol. 2012;91:119-25.
40. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med. 2012;209:1505-17.
41. Ohno T, Morita H, Arae K, Matsumoto K, Nakae S. Interleukin-33 in allergy. Allergy. 2012;67:1203-14.
42. Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125:752-4.
43. Prefontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009;183:5094-103.
44. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol. 2010;185:3472-80.
45. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A. 2010;107:18581-6.
46. Lohning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A. 1998;95:6930-5.
47. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol. 2008;20:791-800.
48. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463:540-4. First description of ILC2, along with references nos. 49 and 50.
49. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367-70. First description of ILC2, along with references nos. 48 and 50.
50. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban Jr JF, et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010;464:1362-6. First description of ILC2, along with references nos. 48 and 49.
51. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011;12:631-8. First description of ILC2 in the lung, along with references nos. 52 and 53.
52. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12:1045-54. First description of ILC2 in the lung, along with references nos. 51 and 53.
53. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055-62. First description of ILC2 in the lung, along with references nos. 51 and 52.
54. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12:21-7.
55. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, et al. IL-33-Responsive Lineage-CD25 + CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs. J Immunol. 2012;188:1503-13. References 55-60 are the first descriptions of involvementof ILC2 in allergen-induced airway inflammation.
56. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity. 2012;36:451-63. References 55-60 are the first descriptions of the involvement of ILC2 in allergen-induced airway inflammation.
57. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol. 2011;12:1071-7. References 55-60 are the first descriptions of the involvement of ILC2 in allergen-induced airway inflammation.
58. Klein Wolterink RG, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol. 2012;42:1106-16. References 55-60 are the first descriptions of the involvement of ILC2 in allergen-induced airway inflammation.
59. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol. 2012;129:216-27. References 55-60 are the first descriptions of the involvement of ILC2 in allergen-induced airway inflammation.
60. Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2012;129:191-8. References 55-60 are the first descriptions of the involvement of ILC2 in allergen-induced airway inflammation.
61. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107:11489-94.
62. Taube C, Tertilt C, Gyulveszi G, Dehzad N, Kreymborg K, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One. 2011;6:e21799.
63. Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol. 2004;113:227-34.
64. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27:615-26.
65. Doherty TA, Khorram N, Chang JE, Kim HK, Rosenthal P, et al. STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. Am J Physiol Lung Cell Mol Physiol. 2012;303:L577-588.
66. Agea E, Russano A, Bistoni O, Mannucci R, Nicoletti I, et al. Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med. 2005;202:295-308.
67. Wingender G, Rogers P, Batzer G, Lee MS, Bai D, et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med. 2011;208:1151-62.
68. Mattner J, Debord KL, Ismail N, Goff RD, Cantu 3rd C, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005;434:525-9.
69. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005;434:520-5.
70. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127:372-81.
71. White DC, Sutton SD, Ringelberg DB. The genus Sphingomonas: physiology and ecology. Curr Opin Biotechnol. 1996;7:301-6.
72. Novey HS, Marchioli LE, Sokol WN, Wells ID. Papain-induced asthma-physiological and immunological features. J Allergy Clin Immunol. 1979;63:98-103.
73. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol. 2000;164:1814-9.
74. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol. 1999;162:1278-86.
75. Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity. 2012;37:649-59.
76. Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, et al. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol. 2011;45:1125-32.
77. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715-731.
78. Rock JR, Hogan BL. Epithelial progenitor cells in lung development, maintenance, repair, and disease. Annu Rev Cell Dev Biol. 2011;27:493-512.
79. Enomoto Y, Orihara K, Takamasu T, Matsuda A, Gon Y, et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol. 2009;124:913-20.
80. Bierman A, Yerrapureddy A, Reddy NM, Hassoun PM, Reddy SP. Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice. Transl Res. 2008;152:265-72.
81. Monticelli LA, Sonnenberg GF, Artis D. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr Opin Immunol. 2012;24:284-9.
82. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11:34-46.
83. Erickson LD, Foy TM, Waldschmidt TJ. Murine B1 B cells require IL-5 for optimal T cell-dependent activation. J Immunol. 2001;166:1531-9.
84. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med. 1989;170:1415-20.
85. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med. 1989;169:2133-48.
86. Busse WW, Lemanske Jr RF, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376:826-34.
87. Mjosberg J, Bernink J, Peters C, Spits H. Transcriptional control of innate lymphoid cells. Eur J Immunol. 2012;42:1916-23.
88. Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, et al. Transcription factor RORalpha is critical for nuocyte development. Nat Immunol. 2012;13:229-36.
89. Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM, et al. Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity. 2012;37:463-74.
90. Bakalian A, Kopmels B, Messer A, Fradelizi D, Delhaye-Bouchaud N, et al. Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration. Res Immunol. 1992;143:129-39.
91. Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 2009;9:125-35.
92. Liang HE, Reinhardt RL, Bando JK, Sullivan BM, Ho IC, et al. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2012;13:58-66.
93. Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 2012;37:634-48. Excellent article demonstrating that Gata3 is required for ILC2 development.
94. Holgate ST. Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol. 2011;128:495-505.
95. Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, et al. Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med. 2009;6:e1000076.
96. Sel S, Wegmann M, Dicke T, Henke W, Yildirim AO, et al. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. J Allergy Clin Immunol. 2008;121:910-6.
97. Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci USA. 2012;109:3451-6.